RARA and prostate cancer: Furthermore, we observed that the expression of RAR subunits in 152-S3c cells was different from vector-transfected and untransfected NRP-152 cells, and that the changes were consistent with what we previously observed in specimens from prostate cancer patients, as well as in primary prostatic epithelial cells compared with prostate cancer cell lines [34,35].